Oxolinic acid
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | J01MB05 (WHO) |
Identifiers | |
| |
CAS Number | 14698-29-4 |
PubChem (CID) | 4628 |
ChemSpider | 4467 |
UNII | L0A22B22FT |
KEGG | D02301 |
ChEBI | CHEBI:138856 |
ChEMBL | CHEMBL416755 |
ECHA InfoCard | 100.035.213 |
Chemical and physical data | |
Formula | C13H11NO5 |
Molar mass | 261.23 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Oxolinic acid is a quinolone antibiotic developed in Japan in the 1970s.[1][2] Dosages 12–20 mg/kg orally administered for five to ten days. The antibiotic works by inhibiting the enzyme DNA gyrase. It also acts as a dopamine reuptake inhibitor and has stimulant effects in mice.[3]
See also
References
- ↑ JP Patent 49138244
- ↑ Gleckman R, Alvarez S, Joubert DW, Matthews SJ (August 1979). "Drug therapy reviews: oxolinic acid". American Journal of Hospital Pharmacy. 36 (8): 1077–9. PMID 384788.
- ↑ Garcia de Mateos-Verchere J, Vaugeois JM, Naudin B, Costentin J (December 1998). "Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 8 (4): 255–9. doi:10.1016/S0924-977X(97)00083-7. PMID 9928913.
This article is issued from Wikipedia - version of the 6/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.